Invenio
Delaware corporation · 3 known investors
Invenio develops rapid on-site tissue imaging systems combined with AI to improve cancer patient care. The company serves pathologists and oncologists with real-time diagnostic tools for cancer detection.
Founders & leadership
JT
Jay TrautmanPresident & CEO, Co-Founder
CF
Chris FreudigerChief Technology Officer, Co-Founder
CF
Christian FreudigerDirector
DC
Doug CrawfordDirector
XX
Xiaoliang XieDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$3MraisedFeb 2021 · 9 investors · Other TechnologyRule 506(b)
▶$3MraisedFeb 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael Ming-Yih WuDirector
- Douglas CrawfordDirector
- Christian FreudigerDirector
- Jay TrautmanExecutive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $3M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedJan 2019 · 9 investors · Other TechnologyRule 506(b)
▶$3.5MraisedJan 2019 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- DANIEL ORRINGERDirector
- DOUGLAS CRAWFORDDirector
- JAY TRAUTMANExecutive Officer, Director
- XIAOLIANG XIEDirector
- CHRISTIAN FREUDIGERDirector
- Offering amount
- $3.7M
- Amount sold
- $3.5M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedDec 2015 · 3 investors · Other TechnologyRule 506(b)
▶$1MraisedDec 2015 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christian FreudigerDirector
- Jay TrautmanExecutive Officer, Director
- Doug CrawfordDirector
- Xiaoliang XieDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.